nVerses Capital’s Equifax EFX Stock Holding History

nVerses Capital’s Portfolio EFX Stock Details EFX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,694	Closed	-$305K	–	371
2026 Q1	$305K	Sell	1,694 -118	-7%	-$23.4K	0.28%	149
2025 Q4	$393K	Buy	+1,812	New	+$397K	0.88%	7

Other funds holding EFX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

SCP

Soroban Capital Partners New York $47.8B AUM 11.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

nVerses Capital's EFX Position: Q2 2026 in Review

nVerses Capital sold out of Equifax (EFX) in Q2 2026, closing a stake of 1,694 shares — an estimated $305K sold.

nVerses Capital first reported a position in EFX in Q4 2025 and held it in 2 quarters. The position peaked at $393K in Q4 2025. 838 funds tracked by Wall St. Rank hold EFX as of Q2 2026.

nVerses Capital reported no remaining Equifax position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 1,694 Equifax shares in Q2 2026, an estimated $305K.
nVerses Capital first reported a position in Equifax in Q4 2025 and held it in 2 quarters.
nVerses Capital's Equifax position peaked at $393K in Q4 2025.
838 funds tracked by Wall St. Rank held Equifax as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.